Tigermed completes cancellation of repurchased shares
Hangzhou Tigermed Consulting (SZSE:300347) has completed the cancellation of 3,922,520 repurchased shares, representing 0.45% of the company's pre-cancellation total share capital. The total value of the cancelled shares amounts to CNY200,046,593.34. With the cancellation finalized on May 29, 2025, the company's total share capital is now 861,026,050 shares, down from 864,948,570. The company stated that the cancellation will not have a material impact on its financial position or operating results and complies with relevant laws and regulations. Tigermed will proceed to update its registered capital and amend its articles of association accordingly.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Hangzhou Tigermed Consulting publishes news
Free account required • Unsubscribe anytime